🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NIH While the indirect rates have in general been to high, it reflects that the direct costs have not been inflation-adjusted for decades. If you do this, put the money back into direct costs that actually fund the research. This is a total disaster for all universities.

🧵 Many “hot takes” about the reduction of NIH indirect grant costs to 15%. Let’s lay out the facts about the university grant management process & accounting. And then use this to project likely short and longer term impacts of the policy.

A pretty sensible and not hyperbolic take on what may be ahead for biomedical research. The most optimistic version may be researchers now control a larger % of the total award, but my god I already hate dealing with line item budgets

💵 💵 ➡️ 📊🧬 Great point re the need for better inflation-adjusted direct costs (and enhancing the actual budget for performing the research itself).

#WhyDukeACES: check out my short commute to work through beautiful #DukeForest. The ease of living and working Discover Durham is amazing. Duke Anesthesiology Duke University School of Medicine Duke Office of Physician-Scientist Development Paul Wischmeyer MD Michael Devinney Brandi Bottiger Leah Acker Jamie Privratsky MD/PhD Working@Duke

#WhyDukeACES: check out what Leah Acker has to say about why she loves working Duke Anesthesiology . Duke Office of Physician-Scientist Development Duke University School of Medicine Michael Devinney Paul Wischmeyer MD Brandi Bottiger

#WhyDukeACES: see what our Vice-Chair for Research Miriam Treggiari says about why she loves Duke Anesthesiology. Duke University School of Medicine Brandi Bottiger Michael Devinney Paul Wischmeyer MD Duke Office of Physician-Scientist Development

Amazing to have WesElyMD at Duke Anesthesiology for our 2025 Duke Critical Care Collaborative Come join this incredible ICU team Duke University School of Medicine ! #FOAMcc #ICURehab #ICU

📣Join us tomorrow afternoon for a Duke #Anesthesiology Grand Rounds #DukeAnesGR #AnesGR, featuring Vanderbilt's Dr. E. Wesley Ely: anesthesiology.duke.edu/events/grand-r….

#WhyDukeACES: see what Michael Devinney says about why he thinks Duke ACES Duke Anesthesiology is great place for #physicianscientist. Duke Office of Physician-Scientist Development Brandi Bottiger Jamie Privratsky MD/PhD

👏Congrats to Dr. Gina Russell, Duke Anesthesiology CA-3 resident, on being awarded the inaugural Society for Pediatric Pain Medicine’s Society for Pediatric Pain Medicine Young Investigator Research Award for her study involving a novel pediatric cardiac surgery population. 🔗anesthesiology.duke.edu/news/anesthesi…

One month away from #Match2025!

👏Congrats to Duke #Anesthesiology investigators & research leadership/staff on our department's ranking as the #4 anesthesiology clinical science department in the nation for NIH funding- solidifying our standing as a leading research institution Duke University School of Medicine in the field.

Achieving #4 ranking in Anesthesiology for NIH funding is a testament to the collective effort of our entire team and shared commitment to advancing medical science. It truly takes a village to foster an environment that not only promotes research but also supports the intricate

Congrats!! Grateful to have you on board!

Nick Davies, MD Duke Anesthesiology Duke ACES ASA® The American Board of Anesthesiology Congrats Nick Davies, MD Duke Anesthesiology Duke ACES Jamie Privratsky MD/PhD !!!

👏Congratulations Nick Davies, MD, and welcome to Duke Anesthesiology! #DukeFamily

Great posters IARS360 mtg in Honolulu by Michael Devinney Jeffry Takla, MD et al Duke Anesthesiology Duke Surgery Stanford Anesthesiology Stanford Surgery Duke ACES

👏 to Duke #Anesthesiology's Katie Martucci PhD (multi-PI) on receiving a five-year $3,488,576 NIH R01 grant to study how smoking withdrawal alters pain processing in the brain and develop interventions for smoking cessation in chronic pain patients. 🔗tinyurl.com/nhf2s7wm

A candidate marker and therapeutic target in sepsis! ASCI member Samir M. Parikh & team show cathepsin K cleavage of angiopoietin-2 produces detrimental Tie2 antagonist fragments in sepsis and inhibition of cathepsin K with odanacatib improved survival in sepsis models: